An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure
NCT05297409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 352
Last updated 2025-08-08
Summary
This prospective observational research will be conducted to assess the burden of hyperkalemia including treatment and disease burden of patients in a long-term continuous care from various aspects including adherence to the medication for hyperkalemia and HR-QoLs.
Conditions
- Hyperkalemia
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-21
- Primary Completion
- 2024-08-28
- Completion
- 2024-08-28
Countries
- Japan
Study Locations
More Related Trials
-
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
NCT02653014 ·Status: COMPLETED ·Phase: PHASE1
-
A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
NCT06185660 ·Status: COMPLETED
-
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
NCT04968184 ·Status: TERMINATED ·Phase: PHASE3
-
Potassium Intake in Patients With Chronic Kidney Disease
NCT00949585 ·Status: COMPLETED ·Phase: NA
-
Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease
NCT03574363 ·Status: COMPLETED ·Phase: PHASE2
-
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
NCT06736184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Tissue K+ in Primary Hyperaldosteronism
NCT04251780 ·Status: COMPLETED
-
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
NCT05056727 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
NCT00890279 ·Status: UNKNOWN ·Phase: PHASE2
-
Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
NCT05347693 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
NCT03528681 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Implementing a High Potassium Diet in Heart Failure Patients
NCT03059680 ·Status: COMPLETED ·Phase: NA
-
Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium
NCT03682497 ·Status: TERMINATED ·Phase: PHASE1
-
Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
NCT05173584 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
NCT01284114 ·Status: COMPLETED ·Phase: PHASE4
-
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
NCT02040441 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia
NCT02875834 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
NCT03283267 ·Status: COMPLETED ·Phase: PHASE1
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074
NCT02228733 ·Status: COMPLETED ·Phase: PHASE1
-
Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial
NCT04714710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Examination of Potassium Levels in Saliva in ESRD Patients
NCT02596386 ·Status: UNKNOWN
-
Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
NCT06237712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
NCT04510792 ·Status: WITHDRAWN
-
Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
NCT01130597 ·Status: COMPLETED ·Phase: PHASE2